These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20957396)

  • 61. Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications.
    Wu JT
    J Clin Lab Anal; 1993; 7(5):293-300. PubMed ID: 8410489
    [TBL] [Abstract][Full Text] [Related]  

  • 62. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples.
    Oak JH; Nakagawa K; Miyazawa T
    J Lipid Res; 2002 Mar; 43(3):523-9. PubMed ID: 11893788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Carbohydrate metabolism].
    Iguchi A; Miura H; Sakamoto N
    Nihon Rinsho; 1993 Aug; 51(8):1961-6. PubMed ID: 8411657
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Proteins modified in the nonenzymatically glycosylation reaction (AGE-proteins)--new markers for diabetes?].
    Zdrojewicz Z; Januszewski A; Kwiatkowska D
    Postepy Hig Med Dosw; 1994; 48(6):689-700. PubMed ID: 7675730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The synergistic effect of antiglycating agents (MB-92) on inhibition of protein glycation, misfolding and diabetic complications in diabetic-atherosclerotic rat.
    Mahdavifard S; Bathaie SZ; Nakhjavani M; Taghikhani M
    Eur J Med Chem; 2016 Oct; 121():892-902. PubMed ID: 26733359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases.
    Méndez JD; Xie J; Aguilar-Hernández M; Méndez-Valenzuela V
    Mol Cell Biochem; 2010 Nov; 344(1-2):185-93. PubMed ID: 20680411
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification and quantification of aminophospholipid-linked Maillard compounds in model systems and egg yolk products.
    Utzmann CM; Lederer MO
    J Agric Food Chem; 2000 Apr; 48(4):1000-8. PubMed ID: 10775341
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products.
    Morgan PE; Dean RT; Davies MJ
    Arch Biochem Biophys; 2002 Jul; 403(2):259-69. PubMed ID: 12139975
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative.
    Nagasawa T; Tabata N; Ito Y; Nishizawa N; Aiba Y; Kitts DD
    Mol Cell Biochem; 2003 Jul; 249(1-2):3-10. PubMed ID: 12956392
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The importance of advanced glycosylation end products in the creation and progression of atherosclerosis in non-insulin-dependent diabetes mellitus].
    Kropiewnicka EH; Paczek L
    Przegl Lek; 2000; 57(5):283-7. PubMed ID: 11057118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glycation of Lysozyme by Glycolaldehyde Provides New Mechanistic Insights in Diabetes-Related Protein Aggregation.
    Mariño L; Maya-Aguirre CA; Pauwels K; Vilanova B; Ortega-Castro J; Frau J; Donoso J; Adrover M
    ACS Chem Biol; 2017 Apr; 12(4):1152-1162. PubMed ID: 28257177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A convenient method for preparation of high-purity, Amadori-glycated phosphatidylethanolamine and its prooxidant effect.
    Miyazawa T; Oak JH; Nakagawa K
    Ann N Y Acad Sci; 2005 Jun; 1043():276-9. PubMed ID: 16037248
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comprehensive Identification of Amadori Compound-Modified Phosphatidylethanolamines in Human Plasma.
    He X; Chen GY; Zhang Q
    Chem Res Toxicol; 2019 Jul; 32(7):1449-1457. PubMed ID: 31188577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Toxicity of advanced glycation end products (Review).
    Kuzan A
    Biomed Rep; 2021 May; 14(5):46. PubMed ID: 33786175
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiglycation activity of thiamin-HCl and benfotiamine in diabetic condition.
    Kousar S; Sheikh MA; Asghar M
    J Pak Med Assoc; 2012 Oct; 62(10):1033-8. PubMed ID: 23866441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parameters for measurement of oxidative stress in diabetes mellitus: applicability of enzyme-linked immunosorbent assay for clinical evaluation.
    Noiri E; Tsukahara H
    J Investig Med; 2005 May; 53(4):167-75. PubMed ID: 15974243
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of phosphatidylethanolamine glycation on lipid-protein interactions and membrane protein thermal stability.
    Levi V; Villamil Giraldo AM; Castello PR; Rossi JP; González Flecha FL
    Biochem J; 2008 Nov; 416(1):145-52. PubMed ID: 18564061
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gramicidin S: a peptide model for protein glycation and reversal of glycation using nucleophilic amines.
    Shakkottai VG; Sudha R; Balaram P
    J Pept Res; 2002 Aug; 60(2):112-20. PubMed ID: 12102724
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of mass spectrometry in studies of glycation processes and diabetes management.
    D'Aronco S; Crotti S; Agostini M; Traldi P; Chilelli NC; Lapolla A
    Mass Spectrom Rev; 2019 Jan; 38(1):112-146. PubMed ID: 30423209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.